Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

Issue 6/2015

Content (5 Articles)

Sarcoma (SH Okuno, Section Editor)

Rhabdomyosarcoma in Adults: New Perspectives on Therapy

Catalina Ruiz-Mesa, John M. Goldberg, Alvaro J. Coronado Munoz, Sarah N. Dumont, Jonathan C. Trent

Sarcoma (SH Okuno, Section Editor)

Immunotherapeutic Approaches to Sarcoma

Melissa Burgess, Hussein Tawbi

Sarcoma (SH Okuno, Section Editor)

Preoperative Therapy for Extremity Soft Tissue Sarcomas

Lara E. Davis, Christopher W. Ryan

Lymphoma (JW Sweetenham, Section Editor)

Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation

Moniba Nazeef, Brad S. Kahl

Lymphoma (JW Sweetenham, Section Editor)

The Role of Infectious Agents, Antibiotics, and Antiviral Therapy in the Treatment of Extranodal Marginal Zone Lymphoma and Other Low-Grade Lymphomas

Laahn H. Foster, Craig A. Portell

May 15
Issue: 5/2015
Jul 15
Issue: 7/2015

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits